Annual Total Assets
$2.43 M
-$1.76 M-42.04%
31 December 2023
Summary:
XTL Biopharmaceuticals annual total assets is currently $2.43 million, with the most recent change of -$1.76 million (-42.04%) on 31 December 2023. During the last 3 years, it has fallen by -$4.08 million (-62.69%). XTLB annual total assets is now -95.60% below its all-time high of $55.11 million, reached on 31 December 2001.XTLB Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$2.93 M
+$502.00 K+20.69%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly total assets is currently $2.93 million, with the most recent change of +$502.00 thousand (+20.69%) on 31 March 2024. Over the past year, it has increased by +$265.00 thousand (+9.95%). XTLB quarterly total assets is now -91.34% below its all-time high of $33.80 million, reached on 30 June 2006.XTLB Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.0% | +9.9% |
| 3 y3 years | -62.7% | -57.3% |
| 5 y5 years | -71.7% | -64.7% |
XTLB Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.3% | at low | -57.3% | +20.7% |
| 5 y | 5 years | -71.7% | at low | -64.7% | +20.7% |
| alltime | all time | -95.6% | +239.3% | -91.3% | +646.9% |
XTL Biopharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.93 M(+20.7%) |
| Dec 2023 | $2.43 M(-42.0%) | $2.43 M(-8.9%) |
| Sept 2023 | - | $2.66 M(-7.6%) |
| June 2023 | - | $2.88 M(-13.3%) |
| Mar 2023 | - | $3.32 M(-20.6%) |
| Dec 2022 | $4.19 M(-36.7%) | $4.19 M(-14.5%) |
| Sept 2022 | - | $4.90 M(-14.9%) |
| June 2022 | - | $5.76 M(-13.0%) |
| Mar 2022 | - | $6.62 M(+0.0%) |
| Dec 2021 | $6.62 M(+1.8%) | $6.62 M(-3.5%) |
| Sept 2021 | - | $6.86 M(-1.4%) |
| June 2021 | - | $6.95 M(-4.9%) |
| Mar 2021 | - | $7.31 M(+12.4%) |
| Dec 2020 | $6.50 M(-9.8%) | $6.50 M(+4.7%) |
| Sept 2020 | - | $6.21 M(-8.5%) |
| June 2020 | - | $6.79 M(-6.6%) |
| Mar 2020 | - | $7.27 M(+0.8%) |
| Dec 2019 | $7.21 M(-15.9%) | $7.21 M(-13.0%) |
| Sept 2019 | - | $8.29 M(-13.2%) |
| June 2019 | - | $9.55 M(-23.2%) |
| Mar 2019 | - | $12.43 M(+45.0%) |
| Dec 2018 | $8.57 M(+30.2%) | $8.57 M(+14.8%) |
| Sept 2018 | - | $7.47 M(+16.1%) |
| June 2018 | - | $6.44 M(+0.1%) |
| Mar 2018 | - | $6.43 M(-2.4%) |
| Dec 2017 | $6.59 M(+118.3%) | $6.59 M(-3.5%) |
| Sept 2017 | - | $6.83 M(-4.8%) |
| June 2017 | - | $7.17 M(-8.0%) |
| Mar 2017 | - | $7.80 M(+158.4%) |
| Dec 2016 | $3.02 M(-43.3%) | $3.02 M(-25.6%) |
| Sept 2016 | - | $4.06 M(-6.5%) |
| June 2016 | - | $4.34 M(-8.8%) |
| Mar 2016 | - | $4.76 M(-10.6%) |
| Dec 2015 | $5.32 M | $5.32 M(-28.9%) |
| Sept 2015 | - | $7.49 M(-4.8%) |
| June 2015 | - | $7.86 M(+56.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $5.01 M(-11.2%) |
| Dec 2014 | $5.64 M(-29.6%) | $5.64 M(-15.6%) |
| Sept 2014 | - | $6.69 M(-7.4%) |
| June 2014 | - | $7.22 M(-6.7%) |
| Mar 2014 | - | $7.74 M(-3.4%) |
| Dec 2013 | $8.02 M(-27.7%) | $8.02 M(-22.0%) |
| Sept 2013 | - | $10.28 M(+9.6%) |
| June 2013 | - | $9.38 M(-10.0%) |
| Mar 2013 | - | $10.42 M(-6.0%) |
| Dec 2012 | $11.09 M(+172.2%) | $11.09 M(+41.1%) |
| Sept 2012 | - | $7.86 M(+7.1%) |
| June 2012 | - | $7.34 M(-6.7%) |
| Mar 2012 | - | $7.86 M(+93.1%) |
| Dec 2011 | $4.07 M(+7.3%) | $4.07 M(-6.7%) |
| Sept 2011 | - | $4.36 M(-7.9%) |
| June 2011 | - | $4.74 M(-7.6%) |
| Mar 2011 | - | $5.12 M(+34.9%) |
| Dec 2010 | $3.80 M(+431.0%) | $3.80 M(-5.0%) |
| Sept 2010 | - | $4.00 M(+919.1%) |
| June 2010 | - | $392.00 K(-23.3%) |
| Mar 2010 | - | $511.00 K(-28.5%) |
| Dec 2009 | $715.00 K(-79.0%) | $715.00 K(-18.1%) |
| Sept 2009 | - | $873.00 K(-74.3%) |
| Dec 2008 | $3.40 M(-75.9%) | $3.40 M(-63.8%) |
| June 2008 | - | $9.38 M(-33.6%) |
| Dec 2007 | $14.13 M(-47.5%) | $14.13 M(+4.2%) |
| June 2007 | - | $13.56 M(-49.6%) |
| Dec 2006 | $26.90 M(+77.5%) | $26.90 M(-20.4%) |
| June 2006 | - | $33.80 M(+123.1%) |
| Dec 2005 | $15.15 M(-40.9%) | $15.15 M(-24.1%) |
| June 2005 | - | $19.97 M(-22.0%) |
| Dec 2004 | $25.62 M(+3.1%) | $25.62 M(+57.3%) |
| June 2004 | - | $16.29 M |
| Dec 2003 | $24.85 M(-35.3%) | - |
| Dec 2002 | $38.42 M(-30.3%) | - |
| Dec 2001 | $55.11 M | - |
FAQ
- What is XTL Biopharmaceuticals annual total assets?
- What is the all time high annual total assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual total assets year-on-year change?
- What is XTL Biopharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly total assets year-on-year change?
What is XTL Biopharmaceuticals annual total assets?
The current annual total assets of XTLB is $2.43 M
What is the all time high annual total assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual total assets is $55.11 M
What is XTL Biopharmaceuticals annual total assets year-on-year change?
Over the past year, XTLB annual total assets has changed by -$1.76 M (-42.04%)
What is XTL Biopharmaceuticals quarterly total assets?
The current quarterly total assets of XTLB is $2.93 M
What is the all time high quarterly total assets for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly total assets is $33.80 M
What is XTL Biopharmaceuticals quarterly total assets year-on-year change?
Over the past year, XTLB quarterly total assets has changed by +$265.00 K (+9.95%)